Massachusetts Healthcare Journal
SEE OTHER BRANDS

Fresh health and wellness news from Massachusetts

Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4

PLANO, Texas, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation in the 2025 Wells Fargo Healthcare Conference, to be held Sept. 3 – 5, in Boston. Members of the Integer executive leadership team will participate in a fireside chat on Thursday, Sept. 4, at 3:00 p.m. ET.

A live webcast of the presentation will be accessible under “News & Events” on the Investor Relations section of the Integer website at investor.integer.net.

Learn more about Integer at www.integer.net.

About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.

Investor Relations: Media Relations:
Kristen Stewart Lauren Ban
kristen.stewart@integer.net lauren.ban@integer.net
551.337.3973 469.476.9615
   

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions